Scorecard › Baskets › Biotech › who's right about biotech

Biotech vs XBI

1 of 5 biotech headliners beat XBI over the last year (1 of 5 over six months, 0 of 5 over three). Every line is measured against the benchmark itself, so the zero line is XBI.

Weekly closes through 2026-09-14. The zero line is the benchmark: a name "beats" when its total return over the window is higher than XBI's. Rebuilt every morning.

Beat XBI over 6M
1 of 5
Beat XBI over 1Y
1 of 5
Beat XBI over 3Y
0 of 5

Total return

Name6Mvs bench1Yvs bench3Yvs benchSince
XBI benchmark +31.1%0+65.0%0+116.2%0
AMGN +9.1% -22.0 +33.0% -32.0 +41.8% -74.4 2021-09
GILD +6.1% -25.0 +27.6% -37.4 +94.1% -22.1 2021-09
VRTX +14.4% -16.7 +35.6% -29.4 +48.6% -67.6 2021-09
REGN +8.4% -22.7 +34.2% -30.8 -3.7% -119.9 2021-09
MRNA +184.3% +153.2 +478.8% +413.8 +46.1% -70.1 2021-09

A name whose history starts inside a window is measured from its first bar, not the window start — the "Since" column says where.

Headliners

AMGNGILDVRTXREGNMRNA

Benchmarks available on the dashboard: XBI, IBB.

The wider biotech universe

The dashboard's Sleepers view screens these 31 lesser-covered names for the ones beating XBI on a trailing basis, with liquidity, price and coverage floors so nothing untradeable or already crowded gets through.

BIIBALNYINCYNBIXSRPTBMRNUTHREXELHALOIONSRAREFOLDKRYSAPLSARWRBEAMNTLACRSPEDITVERVRXRXTWSTDNAACADPTCTAXSMCORTMDGLVKTXAKROTGTX

Other baskets

SemiconductorsSemi EquipmentBig BanksRegional BanksBrokers & ExchangesOil & Gas MajorsOil ServicesNat Gas & LNGPower & GridNuclearSolar & CleanMedical DevicesPharmaRobotics & Physical AIQuantumSportsbooks & iGamingCrypto

Interactive chart with 6M–5Y windows, relative / indexed / drawdown modes and the sleeper screen: Baskets tab.

How the grading works

Every sell-side rating change from the last 365 days is priced the day it lands and checked again 30, 60 and 90 days later. A call is a hit when the stock moved in the called direction at 30 days. Buy- and Sell-side ratings call their own direction. A Hold is read, not waved through: a downgrade to Hold is graded as a bearish call and an upgrade to Hold as a bullish one, and a maintained Hold whose price target sits 10%+ above the price leans bullish (10%+ below, leans bearish) and is graded that way. A Hold with a target close to the price is a true Hold and is not graded at all. Every call with a price target also gets a target check 90 days later: hit (reached it or within 5%), close (covered at least half the distance) or missed. A firm's accuracy on a single name prints only after 4 scored calls, and a firm gets its own page only after 10 scored calls across every covered name — below that a percentage is noise. "Run before the call" is the stock's move over the 30 calendar days before the rating landed. Data: Yahoo Finance rating history and daily closes, rebuilt each morning. Nothing on this page is advice.

Get the 7 AM brief

The AM take, today's docket and the Street's calls — one email, weekdays, before the open.